Atlassian Co. (NASDAQ:TEAM – Get Free Report) CEO Michael Cannon-Brookes sold 7,948 shares of the business’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $265.33, for a total value of $2,108,842.84. Following the completion of the sale, the chief executive officer now owns 365,608 shares in the company, valued at $97,006,770.64. This represents a 2.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Michael Cannon-Brookes also recently made the following trade(s):
- On Wednesday, January 15th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The stock was sold at an average price of $251.20, for a total transaction of $1,996,537.60.
- On Monday, January 13th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The stock was sold at an average price of $236.89, for a total value of $1,882,801.72.
- On Friday, January 10th, Michael Cannon-Brookes sold 15,896 shares of Atlassian stock. The shares were sold at an average price of $243.55, for a total value of $3,871,470.80.
- On Wednesday, January 8th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The shares were sold at an average price of $243.35, for a total transaction of $1,934,145.80.
- On Monday, January 6th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The shares were sold at an average price of $254.95, for a total transaction of $2,026,342.60.
- On Thursday, January 2nd, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The stock was sold at an average price of $242.27, for a total transaction of $1,925,561.96.
- On Monday, December 30th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The stock was sold at an average price of $246.97, for a total value of $1,962,917.56.
- On Thursday, December 26th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The shares were sold at an average price of $255.45, for a total value of $2,030,316.60.
- On Tuesday, December 24th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The shares were sold at an average price of $255.25, for a total transaction of $2,028,727.00.
- On Friday, December 20th, Michael Cannon-Brookes sold 7,948 shares of Atlassian stock. The stock was sold at an average price of $255.22, for a total transaction of $2,028,488.56.
Atlassian Stock Down 0.3 %
Shares of NASDAQ TEAM opened at $264.81 on Friday. The firm has a fifty day simple moving average of $257.68 and a two-hundred day simple moving average of $204.80. The firm has a market capitalization of $68.97 billion, a PE ratio of -174.22 and a beta of 0.83. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.96. Atlassian Co. has a 12 month low of $135.29 and a 12 month high of $287.97.
Institutional Investors Weigh In On Atlassian
Several hedge funds and other institutional investors have recently added to or reduced their stakes in TEAM. Virtu Financial LLC bought a new stake in shares of Atlassian during the 3rd quarter valued at $606,000. Sequoia Financial Advisors LLC boosted its stake in Atlassian by 37.0% during the third quarter. Sequoia Financial Advisors LLC now owns 1,925 shares of the technology company’s stock worth $306,000 after acquiring an additional 520 shares in the last quarter. Fulton Bank N.A. bought a new stake in Atlassian during the fourth quarter worth about $447,000. Paloma Partners Management Co purchased a new stake in Atlassian in the third quarter worth about $1,588,000. Finally, Impax Asset Management Group plc increased its stake in shares of Atlassian by 590.6% during the third quarter. Impax Asset Management Group plc now owns 37,402 shares of the technology company’s stock valued at $5,940,000 after purchasing an additional 31,986 shares in the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. Piper Sandler upped their target price on shares of Atlassian from $265.00 to $310.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Canaccord Genuity Group upped their price objective on Atlassian from $255.00 to $285.00 and gave the stock a “buy” rating in a report on Friday, December 20th. Robert W. Baird raised their price objective on Atlassian from $175.00 to $200.00 and gave the company a “neutral” rating in a report on Friday, November 1st. Jefferies Financial Group upped their target price on Atlassian from $300.00 to $325.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Morgan Stanley lifted their price target on shares of Atlassian from $259.00 to $315.00 and gave the stock an “overweight” rating in a research note on Thursday, January 16th. Nine analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $273.19.
Get Our Latest Stock Report on Atlassian
About Atlassian
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.
Read More
- Five stocks we like better than Atlassian
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Bloom Energy: Powering the Future With Decentralized Energy
- ESG Stocks, What Investors Should Know
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.